http://ideas.eyeconx.net/story.php?title=fewer-ranibizumab-injections-same-visual-acuity-in-amd Patients with neovascular age-related macular degeneration (nAMD) who receive intravitreal ranibizumab injections on an individualized schedule have the same visual acuity gains as patients treated on a standard monthly schedule, and individualized plans reduce the number of office visits and injections, according to a single-institution phase 4 study. Irmela Mantel, MD, from the Ophthalmology Dep... Tue, 09 Oct 2012 15:48:35 EDT en